SARKUEX Trademark

Trademark Overview

On Monday, December 4, 2017, a trademark application was filed for SARKUEX with the United States Patent and Trademark Office. The USPTO has given the SARKUEX trademark a serial number of 87706770. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 7, 2025. This trademark is owned by Sanofi. The SARKUEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of cancer
sarkuex

General Information

Serial Number87706770
Word MarkSARKUEX
Filing DateMonday, December 4, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 7, 2025
Registration Number5544495
Registration DateTuesday, August 21, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 5, 2018

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 7, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressParis 75017
FR
Party NameSanofi
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
Address75008 Paris
FR
Party NameSanofi
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address75008 Paris
FR

Trademark Events

Event DateEvent Description
Friday, January 12, 2018ASSIGNED TO EXAMINER
Thursday, December 7, 2017NEW APPLICATION ENTERED
Thursday, December 14, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 18, 2018SUSPENSION LETTER WRITTEN
Thursday, January 18, 2018LETTER OF SUSPENSION E-MAILED
Thursday, January 18, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 12, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, April 21, 2018ASSIGNED TO LIE
Monday, April 23, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 23, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 16, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 5, 2018PUBLISHED FOR OPPOSITION
Tuesday, June 5, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 8, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Friday, March 3, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 3, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, August 21, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, March 7, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

sarkuex cancer treatment prevention products pharmaceutical